Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?4.0 RB, SLActive? 14mm, RXD: medical device reports filed with FDA

1,440 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,440
device reports naming the brand
0% of all MAUDE reports · about 213 a year
328
reports, 12 months to August 2026
286 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,440 reports that name the brand "BLX ?4.0 RB, SLActive? 14mm, RXD" (endosseous dental implant), received between October 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

328 reports arrived in the 12 months to August 2026, up 15% from 286 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (66.6%), loss of osseointegration (14%) and difficult to insert (2.2%). The patient problems coded most often are fibrosis, pain and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03264Sep 2021: 16Oct 2021: 8Nov 2021: 19Dec 2021: 92022Jan 2022: 13Feb 2022: 5Mar 2022: 15Apr 2022: 14May 2022: 32Jun 2022: 6Jul 2022: 18Aug 2022: 36Sep 2022: 12Oct 2022: 19Nov 2022: 17Dec 2022: 192023Jan 2023: 14Feb 2023: 26Mar 2023: 27Apr 2023: 25May 2023: 25Jun 2023: 23Jul 2023: 17Aug 2023: 31Sep 2023: 25Oct 2023: 20Nov 2023: 20Dec 2023: 162024Jan 2024: 11Feb 2024: 29Mar 2024: 17Apr 2024: 22May 2024: 25Jun 2024: 17Jul 2024: 11Aug 2024: 28Sep 2024: 39Oct 2024: 25Nov 2024: 21Dec 2024: 252025Jan 2025: 14Feb 2025: 24Mar 2025: 25Apr 2025: 10May 2025: 0Jun 2025: 64Jul 2025: 19Aug 2025: 20Sep 2025: 19Oct 2025: 17Nov 2025: 24Dec 2025: 362026Jan 2026: 24Feb 2026: 30Mar 2026: 45Apr 2026: 26May 2026: 17Jun 2026: 26Jul 2026: 33Aug 2026: 31

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01362722019: 620192020: 5720202021: 12820212022: 20620222023: 26920232024: 27020242025: 27220252026: 2322026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,440
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report75.6%1,089
Voluntary report0%0
User facility report0%0
Distributor report24.4%351
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate95966.6%62.8%
Loss of osseointegration20114%22.4%
Difficult to insertthe device was hard to insert322.2%0.4%
Fracturea broken bone40.3%1.6%
Separation failure40.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis42929.8%
Painpain, site not specified26818.6%
Hemorrhage/blood loss/bleeding694.8%
Inflammationinflammation594.1%
Hyperresponsive to stimuli473.3%
Swelling/ edema422.9%
Tissue damage362.5%
Fistula322.2%
Abscessa collection of pus281.9%
Hypersensitivity/allergic reaction100.7%
Numbnessnumbness100.7%
Sinus perforation30.2%
Swellingswelling20.1%
Inadequate osseointegration10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?4.0 RB, SLActive? 14mm, RXDProduct code DZEAll MAUDE reports
Reports1,4403,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer75.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?4.0 RB, SLActive? 14mm, RXD reports

How many FDA reports name BLX ?4.0 RB, SLActive? 14mm, RXD?

1,440 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 328 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (66.6%), loss of osseointegration (14%), difficult to insert (2.2%), fracture (0.3%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (75.6%) and distributor reports (24.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?4.0 RB, SLActive? 14mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.